Xpert® Xpress CoV-2 plus

Home / Tests / Respiratory

Designed with 3 gene targets for a rapid, robust detection of SARS-CoV-2

Test pack size(s)

10 Tests

XP3SARS-COV2-10

Qty

Unit price

Subtotal

USD

$0.00

Collection devices

Copan 346N (Nasal Swab) (Pack of 50)

346C

Qty

Unit price

Subtotal

USD

$0.00

Total

$0.00

The Need

Rapidly detect SARS-CoV-2, including emerging variants, to provide timely, effective triage
Increase workflow efficiencies with minimal hands-on time

Test

The Solution

The Xpert Xpress CoV-2 plus test provides:

Fast and accurate results in as early as 20 minutes*
Three gene targets for SARS-CoV-2 as well as an optimization of SARS-CoV-2 probes to enable more realizable virus detection
Rapid sample-to-answer testing with actionable results from a single sample

*With early assay termination for positives, otherwise, the full test runtime is 30 minutes.

The Impact

Offers healthcare providers lab-quality results in a test that can be performed at the point of care
Supports clinicians with broader coverage for SARS-CoV-2 variants with a three-gene design
Enables hospitals to effectively manage limited resources with our single-cartridge technology and easy-to-use workflow

In the United States: This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories; This product has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries